Dr Fraser O'Rourke
- Honorary Clinical Fellow (Undergraduate Medical School)
email:
Fraser.ORourke@gla.systa-s.com
University Hospital Wishaw, 50 Netherton Street, Wishaw, ML2 0DP
Publications
2025
Thompson, Joshua J., MacLeod, Nicholas, Will, Sarah, O'Rourke, Fraser, McGovern, Josh, Roxburgh, Campbell 
ORCID: https://orcid.org/0000-0002-2649-6695, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dolan, Ross D. ORCID: https://orcid.org/0000-0002-5272-5906 and McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334
(2025)
The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer.
BMC Cancer, 25,
543.
(doi: 10.1186/s12885-025-13426-3)
(PMID:40133911)
(PMCID:PMC11938618)
2024
McGovern, J. et al. (2024) The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: comparison of composite ratios and cumulative scores. Cancer Medicine, 13(16), e70139. (doi: 10.1002/cam4.70139) (PMCID:PMC11335809)
Articles
Thompson, Joshua J., MacLeod, Nicholas, Will, Sarah, O'Rourke, Fraser, McGovern, Josh, Roxburgh, Campbell ORCID: https://orcid.org/0000-0002-2649-6695, Edwards, Joanne ORCID: https://orcid.org/0000-0002-7192-6906, Dolan, Ross D. ORCID: https://orcid.org/0000-0002-5272-5906 and McMillan, Donald C. ORCID: https://orcid.org/0000-0003-4260-5334
(2025)
The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer.
BMC Cancer, 25,
543.
(doi: 10.1186/s12885-025-13426-3)
(PMID:40133911)
(PMCID:PMC11938618)
McGovern, J. et al. (2024) The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: comparison of composite ratios and cumulative scores. Cancer Medicine, 13(16), e70139. (doi: 10.1002/cam4.70139) (PMCID:PMC11335809)